Literature DB >> 28710899

Effects of dobutamine, dopamine, phenylephrine and noradrenaline on systemic haemodynamics and intestinal perfusion in isoflurane anaesthetised horses.

C Dancker1, K Hopster1, K Rohn2, S B Kästner1,3.   

Abstract

BACKGROUND: In the horse, effects of cardiovascular-active drugs on local perfusion of the gastrointestinal tract are poorly understood.
OBJECTIVES: To determine the effect of drugs commonly used to support blood pressure, on local intestinal blood flow and tissue oxygenation under isoflurane anaesthesia. STUDY
DESIGN: In vivo randomised crossover experiment.
METHODS: Ten horses were anaesthetised with isoflurane. After 90 min of equilibration three doses (μg/kg bwt/min) of dobutamine (DOB 0.5/1/3), dopamine (DA 1/2/5), noradrenaline (NA 0.1/0.2/0.5) and phenylephrine (PHE 0.5/1/3) were infused for 15 min, in a randomised order, with a 45 min washout-period. Blood flow and tissue oxygenation (sO2 ) of jejunum, colon and stomach were measured using white light remission spectrophotometry and laser doppler flowmetry; heart rate (HR), mean arterial blood pressure (MAP), cardiac output (CO) were measured and systemic vascular resistance (SVR) calculated.
RESULTS: Compared to baseline high dose dobutamine significantly increased CO, HR, MAP (P<0.001) and blood flow to the jejunum (+47 ± 26%, P = 0.001) and colon (+29 ± 15%, P<0.001) (mean ± s.d.). Dopamine (DA5) increased CO but decreased colonic blood flow (-39 ± 21% from baseline, P<0.001), as well as SVR and MAP compared to baseline (P<0.001). Noradrenaline had no significant influence on intestinal perfusion, but increased MAP and SVR from baseline (P<0.001). Phenylephrine (PHE3) caused a significant decrease in blood flow and sO2 , most profoundly at the colon compared to baseline (flow -44 ± 21%; sO2 -16 ± 3%, P<0.001), while MAP and SVR increased and CO and HR decreased (P<0.001). MAIN LIMITATIONS: The measurement technique only allows for flow measurements in arbitrary units, which can limit comparability to other techniques.
CONCLUSION: At the investigated doses dobutamine improved systemic and peripheral haemodynamics, while dopamine decreased MAP and peripheral perfusion. Noradrenaline increased MAP and SVR while peripheral blood flow was maintained, phenylephrine increased MAP, but reduced both local and systemic perfusion.
© 2017 EVJ Ltd.

Entities:  

Keywords:  catecholamines; horse; microcirculation; splanchnic circulation; vasoconstrictor agents

Mesh:

Substances:

Year:  2017        PMID: 28710899     DOI: 10.1111/evj.12721

Source DB:  PubMed          Journal:  Equine Vet J        ISSN: 0425-1644            Impact factor:   2.888


  5 in total

1.  Parasympathetic Tone Changes in Anesthetized Horses after Surgical Stimulation, and Morphine, Ketamine, and Dobutamine Administration.

Authors:  Patricia Ruíz-López; Juan Morgaz; Setefilla Quirós-Carmona; Rocío Navarrete-Calvo; Juan Manuel Domínguez; Rafael Jesús Gómez-Villamandos; M M Granados
Journal:  Animals (Basel)       Date:  2022-04-15       Impact factor: 3.231

2.  Suspicion of Postanesthetic Femoral Paralysis of the Non-Dependent Limb in a Horse.

Authors:  Alessandro Mirra; Micaël David Klopfenstein Bregger; Olivier Louis Levionnois
Journal:  Front Vet Sci       Date:  2018-02-07

3.  Short-term infusion of ultralow-dose dopamine in an adult horse with acute kidney injury: A case report.

Authors:  Hiroshi Matsuda; Kenshiro Matsuda; Ryo Muko; Masa-Aki Oikawa; Akane Tanaka
Journal:  Vet Anim Sci       Date:  2021-04-11

4.  Effect of 15° Reverse Trendelenburg Position on Arterial Oxygen Tension during Isoflurane Anesthesia in Horses.

Authors:  Laura Tucker; Daniel Almeida; Erin Wendt-Hornickle; Caroline F Baldo; Sandra Allweiler; Alonso G P Guedes
Journal:  Animals (Basel)       Date:  2022-02-01       Impact factor: 2.752

5.  Intraoperative systemic vascular resistance is associated with postoperative nausea and vomiting after laparoscopic hysterectomy.

Authors:  Meng-Di Qu; Meng-Yuan Zhang; Gong-Ming Wang; Zhun Wang; Xu Wang
Journal:  World J Clin Cases       Date:  2020-10-26       Impact factor: 1.337

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.